摘要
为了研究异体ＬＡＫ／ＩＬ２治疗的最佳方案，将２４例晚期肝癌分为３个不同疗程的治疗组，结果显示反复多次ＬＡＫ／ＩＬ２治疗组效果优于单次治疗组及对照组。
Twenty four cases of advanced liver cancer,having been treated by combination of the LAK cells and IL 2,were divided into three groups according to therapentic courses.The result shows that the effect in the treatment of the group,repeatedly treated by LAK cells combining IL 2,is better than in other groups.It suggests that combination of the LAK cells and IL 2 in the treatment of the advanced cancer need to be used repeatedly.
出处
《实用癌症杂志》
1999年第1期33-34,共2页
The Practical Journal of Cancer
